Ireland: Healthcare

The European Medicines Agency offers special status to micro, small and medium-sized enterprises developing medicines, providing financial incentives, translation services, and regulatory guidance to foster innovation. Companies meeting specific employee and financial thresholds can access fee reductions, deferred payments, and expert support through the EMA's SME office.

Less than a year before the transposition of the revised Product Lability Directive1, the Court of Justice of the European Union (“CJEU”) has provided some welcome clarification on the application of the limitation periods...

This report examines how deal activity in the life sciences and healthcare sector performed during 2025, highlighting key trends, significant transactions and emerging themes shaping the market. The report also looks ahead to 2026, considering the factors likely to influence M&A activity in Ireland in the year ahead.

Artificial Intelligence (AI) is playing an increasingly prominent role in the Irish healthcare system, particularly in areas such as medical imaging and diagnostics.

RDJ's Healthcare Department were involved in successfully resisting an appeal where the Court of Appeal has upheld a modular trial Order confirming strategic case management...

In Northern Ireland, the festive season often prompts renewed attention on alcohol licensing laws.

The new Product Liability Directive marks the most significant overhaul of product liability law in nearly four decades.

This article provides an overview of M&A activity in the healthcare and life sciences sector during 2024 and the outlook for 2025.

Ireland's National Energy Demand Strategy outlines regulatory decisions around smart energy services and customer demand flexibility and response.